Home › Companies › ABCELLERA BIOLOGICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ABCELLERA BIOLOGICS INC.’s Form 8-K, filed 2024-06-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024 2024-2025
Explore ABCELLERA BIOLOGICS INC. in the interactive database Compare manager voting policies
These tallies are ABCELLERA BIOLOGICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Véronique Lecault, Ph.D. | 167,328,506 | 6,868,582 | 15,059,808 | -- | -- | Majority: yes |
| Elect Director: Andrew Lo, Ph.D. | 152,914,311 | 6,017,047 | 30,325,538 | -- | -- | Majority: yes |
| The broker non-votes for this Proposal 1 totaled 23,405,619 common shares. Proposal 2 The Company's shareholders approved Proposal 2. | 211,978,251 | 306,801 | 377,463 | -- | -- | Majority: yes |
| Proposal 3 The Company's shareholders approved` Proposal 3. | 176,566,724 | 7,454,852 | 5,235,320 | -- | -- | Majority: yes |
Source: ABCELLERA BIOLOGICS INC., Form 8-K, filed with the SEC on 2024-06-13 — read the filing on EDGAR.
Each item below shows how the 123 asset managers that disclosed a ABCELLERA BIOLOGICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ABCELLERA BIOLOGICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 13 wordings of this item as funds reported it.
85% fund support · no official result
The 118 asset managers below cast 85% of the shares they voted on this item FOR (70,828,117 for, 12,584,038 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 26,125,640 | 0 | 0 | 0 | For |
| Capital Group | 0 | 9,649,130 | 0 | 0 | Against |
| BAILLIE GIFFORD & CO LTD | 7,820,505 | 0 | 0 | 0 | For |
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Voya | 4,490,520 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 4,180,768 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 4,105,095 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 3,873,412 | 200 | 0 | 0 | For |
| UBS | 3,633,506 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 2,374,800 | 0 | 0 | Against |
| Lazard | 1,863,106 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,126,915 | 0 | 0 | 0 | For |
| NICOLA WEALTH MANAGEMENT LTD. | 1,013,580 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| Two Sigma | 624,534 | 0 | 0 | 0 | For |
| Mediolanum International Funds Ltd | 0 | 555,383 | 0 | 0 | Against |
| BESSEMER INVESTMENT MANAGEMENT LLC | 531,175 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Baillie Gifford Investment Management (Europe) Ltd | 432,563 | 0 | 0 | 0 | For |
| DE Shaw | 343,085 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| BlackRock | 254,904 | 0 | 0 | 0 | For |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 250,248 | 0 | 0 | 0 | For |
| American Century | 169,658 | 0 | 0 | 0 | For |
Showing the 25 largest of 118 asset managers. See all 118 in the interactive database.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ABCELLERA BIOLOGICS INC.’s own tally for this item (“Elect Director: Andrew Lo, Ph.D.”): 152,914,311 for, 6,017,047 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 294,054,356 outstanding shares: 52.0% for, 2% against (54.0% of the company cast a for/against vote).
The 20 asset managers below cast 99.4% of the shares they voted on this item FOR (12,473,163 for, 72,000 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 0 | 531,175 | 0 | Abstain |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 289,836 | 0 | Abstain |
| Lazard | 0 | 0 | 147,984 | 0 | Abstain |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 107,941 | 0 | Abstain |
| American Century | 0 | 0 | 84,829 | 0 | Abstain |
| Federated Hermes | 0 | 72,000 | 0 | 0 | Against |
| State Street | 42,369 | 0 | 0 | 0 | For |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 25,000 | 0 | Abstain |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 2,034 | 0 | Abstain |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 99 | 0 | Abstain |
| ETFis Series Trust I | 0 | 0 | 22 | 0 | Abstain |
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
ABCELLERA BIOLOGICS INC.’s own tally for this item (“Elect Director: Véronique Lecault, Ph.D.”): 167,328,506 for, 6,868,582 against, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 294,054,356 outstanding shares: 57% for, 2% against (59% of the company cast a for/against vote).
The 20 asset managers below cast 100% of the shares they voted on this item FOR (13,691,714 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| Lazard | 147,984 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 107,941 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
| Federated Hermes | 72,000 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 42,369 | 0 | Abstain |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 25,000 | 0 | 0 | 0 | For |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 2,034 | 0 | 0 | 0 | For |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
| Invesco | 99 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 22 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 17 asset managers below cast 100% of the shares they voted on this item FOR (13,179,800 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Virtus | 6,133,665 | 0 | 0 | 0 | For |
| Capital Group | 4,824,565 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD FUNDS | 835,455 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 531,175 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 289,836 | 0 | 0 | 0 | For |
| Lazard | 147,984 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 119,399 | 0 | 0 | 0 | For |
| Listed Funds Trust | 107,941 | 0 | 0 | 0 | For |
| American Century | 84,829 | 0 | 0 | 0 | For |
| State Street | 42,369 | 0 | 0 | 0 | For |
| BlackRock | 25,615 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 25,000 | 0 | 0 | 0 | For |
| Fidelity | 5,360 | 0 | 0 | 0 | For |
| Brighthouse | 4,452 | 0 | 0 | 0 | For |
| ProShares | 2,034 | 0 | 0 | 0 | For |
| Invesco | 99 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 22 | 0 | 0 | 0 | For |
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (554,283 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 480,383 | 0 | 0 | 0 | For |
| Federated Hermes | 72,000 | 0 | 0 | 0 | For |
| Gabelli | 1,900 | 0 | 0 | 0 | For |
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (9,665,032 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| TD ASSET MANAGEMENT INC | 9,658,858 | 0 | 0 | 0 | For |
| Desjardins Global Asset Management Inc. | 6,174 | 0 | 0 | 0 | For |
| IPConcept (Luxemburg) S.A. | 0 | 0 | 0 | 0 | -- |
Ranked by the number of ABCELLERA BIOLOGICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 294,054,356 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 8.88% |
| 2 | Capital Group | 3.28% |
| 3 | BAILLIE GIFFORD & CO LTD | 2.66% |
| 4 | Virtus | 2.09% |
| 5 | Voya | 1.53% |
| 6 | ORBIMED ADVISORS LLC | 1.42% |
| 7 | ArrowMark Colorado Holdings LLC | 1.40% |
| 8 | BAILLIE GIFFORD OVERSEAS LTD | 1.32% |
| 9 | UBS | 1.24% |
| 10 | Man Group plc | 0.81% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Carl L.G. Hansen | 20.66% | 13G |
| Thermopylae Holdings Ltd. | 18.98% | DEF14A |
| Baillie Gifford & Co | 8.18% | DEF14A |
| Baker Bros. Advisors LP | 7.79% | DEF14A |
| Véronique Lecault, Ph.D. | 4.05% | DEF14A |
| Andrew Booth | 1.89% | DEF14A |
| BlackRock | 1.24% | 13F |
| Morgan Stanley | 0.95% | 13F |
| Tryn Stimart | 0.72% | DEF14A |
| Michael Hayden, MBCHB (M.D.), Ph.D. | 0.64% | DEF14A |
Percentages above are of 294,054,356 shares outstanding, as reported by ABCELLERA BIOLOGICS INC. on its Form 10-Q dated 2024-05-01 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ABCELLERA BIOLOGICS INC.’s 10-Q dated 2024-05-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ABCELLERA BIOLOGICS INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 123 asset managers reported how they voted in their SEC Form N-PX filings, covering 250 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. ABCELLERA BIOLOGICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation of the Company's named executive… — the reporting funds cast 85% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
ABCELLERA BIOLOGICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.